Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-30, Stock:JNJ, The news for the past five days is as follows:
2021-06-23: NEWS1: ‘Vaccination is very effective against the Delta variant’: Doctor.NEWS2: U.S. House panels expand probe into Emergent's Baltimore COVID-19 vaccine plant.NEWS3: Halozyme (HALO) Inks Collaboration Deal With Glaxo's HIV Unit.NEWS4: Does Johnson & Johnson Have the Safest Dividend in Healthcare?.NEWS5: Africa’s third wave: ‘What haunts me a lot is the Indian scenario’.
2021-06-24: NEWS1: 10 Medical Device Stocks for 2021.NEWS2: Top Analyst Reports for Tesla, Alibaba & Johnson & Johnson.NEWS3: ‘Unchecked spread in the U.S. is going to lead to other problems’: Doctor.NEWS4: A Covid underclass is forming.NEWS5: UPDATE 2-EU slightly cuts estimates for vaccine deliveries this year.NEWS6: J&J (JNJ)/Bayer Seek Nod for Xarelto for Blood Clots in Kids.NEWS7: Top 25 S&P 500 Stocks By Index Weight.NEWS8: Pharma Stock Roundup: EU Nod to AZN, SNY, JNJ Drugs, Glaxo's New COVID-19 Drug Data.NEWS9: mRNA vaccine-makers’ stocks take a hit amid possible link to rare heart conditions.
2021-06-25: NEWS1: Booster may be needed for J&J shot as Delta variant spreads, some experts already taking them.NEWS2: Zero N.J. Deaths, Pressure Mounts on U.K. Minister: Virus Update.NEWS3: It’s concerning seeing variants popping up all over the world: Doctor.NEWS4: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS5: UPDATE 3-Amid J&J's supply woes, EU approves new COVID-19 vaccine plant.NEWS6: EU regulator approves Italian site for J&J COVID-19 vaccine production.NEWS7: UPDATE 1-South Africa to ramp up COVID-19 vaccinations as opposition protests.NEWS8: The Zacks Analyst Blog Highlights: Tesla, Alibaba, Johnson & Johnson, Toyota Motor and 3M.NEWS9: UPDATE 3-Denmark continues exclusion of J&J, AstraZeneca COVID-19 vaccines.NEWS10: South Africa aims to more than double daily COVID-19 vaccinations over next month.NEWS11: Ignore Biogen: Here Are 3 Better Stocks.
2021-06-28: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: It’s been a ‘very traumatic experience’ for India after second COVID-19 wave: Journalist.NEWS3: IMF says Africa urgently needs vaccines to halt repeated COVID waves.NEWS4: Earnings Roundup: Adobe, Kroger, The Honest Company, and More.NEWS5: Delta variant is getting people in the public health world nervous: Doctor.NEWS6: AstraZeneca (AZN) Gets CHMP Nod for Forxiga in Kidney Disease.NEWS7: 3 Low-Risk Stocks for Conservative Investors.NEWS8: RPT-Booster may be needed for J&J shot as Delta variant spreads, some experts already taking them.NEWS9: Boeing, Tesla and Johnson & Johnson Fall Premarket.NEWS10: U.S. Futures Flat; Near Record Levels Ahead of Payrolls.NEWS11: J&J Falls On Agreeing To Pay $230 Million To Settle Opioid Case.
2021-06-29: NEWS1: Ireland allows AstraZeneca vaccine for all adults, cuts dose gap.NEWS2: Will This 2020 Biotech IPO Crush the Market This Year?.NEWS3: Why Johnson & Johnson Is Trashing 60 Million Doses of Its COVID Vaccine.NEWS4: 3 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell.NEWS5: New York takes Teva, McKesson, others to trial over opioids.NEWS6: UPDATE 2-J&J explores ways to speed up delivery of its COVID-19 vaccine in India.NEWS7: REFILE-J&J decides not to conduct trials in India for its COVID-19 vaccine - ET.

Answer: Rise